Five Years On: UK Reviews Transposition Of EU Pharmacovigilance Directive, Other Changes
Executive Summary
The UK medicines regulator is undertaking a post-implementation review of the Human Medicines Regulations 2012, which introduced significant changes for the medicines sector such as national requirements in relation to the EU pharmacovigilance directive.
You may also be interested in...
New law consolidating over 40 years of UK drugs legislation enters into force
The Human Medicines Regulations 2012 has entered into force in the UK, consolidating and simplifying over 40 years of the country's drugs legislation in such a way as to reduce regulatory burden on businesses1,2.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.